Hinge Health director granted 3,837 RSUs

Hinge Health, Inc. director Leslie Kristina M received an equity compensation award in the form of restricted stock units.

Rhea-AI Filing Summary

Hinge Health, Inc. director Leslie Kristina M received an equity compensation award in the form of restricted stock units. On June 3, 2026, she was granted 3,837 shares of Class A Common Stock at a reference value of $52.12 per share.

The award consists of 3,837 restricted stock units (RSUs) issued under the company’s Non-Employee Director Compensation Program for board service. These RSUs vest according to the award’s terms, and each RSU converts into one share of Class A Common Stock upon settlement. Following this grant, Leslie Kristina M directly owns 31,587 shares of Class A Common Stock.

Insider Trade Summary

Grant/Award: 3,837 shares

Grant/Award 1 txn

Insider Leslie Kristina M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	3,837	$52.12	$200K

Holdings After Transaction: Class A Common Stock — 31,587 shares (Direct)

Footnotes (2)

1. F1. Includes 3,837 restricted stock units ("RSUs") issued to the Reporting Person as compensation for board service pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program"). The RSUs vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement.
2. F2. Calculated in accordance with the Program.

Key Figures

RSUs granted: 3,837 shares Grant value per share: $52.12 per share Total shares after grant: 31,587 shares +2 more

5 metrics

RSUs granted 3,837 shares Equity award for board service on June 3, 2026

Grant value per share $52.12 per share Reference value for Class A Common Stock RSUs

Total shares after grant 31,587 shares Leslie Kristina M direct holdings following the transaction

Transaction code A Grant, award, or other acquisition of non-derivative securities

Security type Class A Common Stock Underlying security for granted restricted stock units

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, contingent right, Class A Common Stock

4 terms

restricted stock units ("RSUs") financial

"Includes 3,837 restricted stock units ("RSUs") issued to the Reporting Person as compensation for board service"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"as compensation for board service pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program")"

contingent right financial

"Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement"

Class A Common Stock financial

"Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HNGE director Leslie Kristina M receive in this Form 4 filing?

Leslie Kristina M received an equity award of 3,837 restricted stock units (RSUs) of Hinge Health, Inc. Each RSU represents the right to receive one share of Class A Common Stock upon settlement, subject to the award’s vesting terms.

How many HNGE shares does Leslie Kristina M own after this RSU grant?

After the reported RSU grant, Leslie Kristina M directly owns 31,587 shares of Hinge Health Class A Common Stock. This total reflects her holdings immediately following the acquisition of 3,837 RSUs reported in the Form 4 filing.

What is the value per share used for the HNGE RSU grant to Leslie Kristina M?

The Form 4 lists a value of $52.12 per share for the 3,837 Class A Common Stock units granted. This figure is calculated in accordance with Hinge Health’s Non-Employee Director Compensation Program, which governs director equity compensation terms.

What are RSUs in the context of Hinge Health (HNGE) director compensation?

Restricted stock units (RSUs) are equity awards that convert into shares after vesting. For Hinge Health, each RSU granted to director Leslie Kristina M entitles her to receive one share of Class A Common Stock upon settlement, following the award’s vesting schedule.

Why did HNGE grant 3,837 RSUs to director Leslie Kristina M?

The 3,837 RSUs were issued to Leslie Kristina M as compensation for board service under Hinge Health’s Non-Employee Director Compensation Program. This program defines how non-employee directors are compensated in equity for their ongoing service.

Do the HNGE RSUs granted to Leslie Kristina M vest immediately?

The RSUs granted to Leslie Kristina M vest in accordance with the terms of the award, meaning they do not necessarily vest immediately. Vesting occurs over time or upon conditions defined in the Non-Employee Director Compensation Program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 06:51 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leslie Kristina M

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/03/2026		A		3,837(1)	A	$52.12(2)	31,587	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 3,837 restricted stock units ("RSUs") issued to the Reporting Person as compensation for board service pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program"). The RSUs vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement.

2. Calculated in accordance with the Program.

	/s/ James Budge, Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)